Trials / Completed
CompletedNCT04762095
The Effect of Mindfulness Stress Reduction Program on Menopausal Complaints and Quality of Life
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 113 (actual)
- Sponsor
- NURDİLAN SENER · Academic / Other
- Sex
- Female
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The study was conducted to determine the effect of the mindfulness stress reduction program (MBSR) applied to postmenopausal women on menopausal complaints and quality of life. The population of the study was 2626 women and the sample was composed of 55 experimental and 63 control groups, totally 118 women. The data of the study were collected using Personal Information Form, Mindful Attention Awareness Scale (MAAS), Menopausal Symptoms Assessment Scale (MSAS) and Menopause Specific Quality of Life Scale (MYQOL).
Detailed description
Aim: The study was conducted to determine the effect of the mindfulness stress reduction program (MBSR) applied to postmenopausal women on menopausal complaints and quality of life. Materials and Methods: Research is quasi-experimental. The population of the study was 2626 women and the sample was composed of 55 experimental and 63 control groups, totally 118 women. The data of the study were collected using Personal Information Form, Mindful Attention Awareness Scale (MAAS), Menopausal Symptoms Assessment Scale (MSAS) and Menopause Specific Quality of Life Scale (MYQOL). In the study, an 8-week Mindfulness Stress Reduction Program was applied to the women in the experimental group. In the study, mid-test and post-test (MAAS, MSAS, MYQOL) were applied 8 and 16 weeks after the pre-test. Descriptive statistics, independent groups t test, chi-square test, ANOVA, Mauchly's test and Cronbach Alpha analysis were used to evaluate the data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | mindfulness stress reduction program | mindfulness stress reduction program |
Timeline
- Start date
- 2019-03-29
- Primary completion
- 2019-09-03
- Completion
- 2021-01-20
- First posted
- 2021-02-21
- Last updated
- 2021-11-30
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04762095. Inclusion in this directory is not an endorsement.